Seoul
Seoul
Seoul, Gangnamgu, South Korea2 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Lazertinib for NSCLC Harboring Activating EGFR Mutations in TKI naïve Patients | non-small cell lung carcinoma | Active, not recruiting | Phase 2 | 2026-07-28 | NCT05463224 | |
| Partial Synovectomy in Articular Side of Quadriceps Tendon Verified to Reduce Crepitus in Retrospective Study | Skin and Connective Tissue Diseases, arthritic joint disease, arthropathy, autoimmune disease, connective tissue disorder, immune system disorder, musculoskeletal system disorder, osteoarthritis, osteoarthritis, knee, rheumatic disorder, rheumatoid arthritis | Recruiting | Not applicable | 2025-02-21 | NCT06129214 |